The monoterpene glycoside paeoniflorin (PF, 1) is a unique biologically active
secondary metabolite
-induced nephropathy (KIN) and
secondary – the increase of markers.
Results: 26 patients were randomized for IP (60
and
secondary – change of biomarkers (creatinine, urea, neutrophil gelatinase-associated lipocalin (NGAL
Zagidullin, N.S.,
Dunayeva, A.R.,
Plechev, V.V.,
Gilmanov, A.Z.,
Zagidullin, S.Z.,
Er, F.,
Pavlov, V.N. (2017) the development of CIN and
secondary – change of biomarkers (creatinine, urea, neutrophil gelatinase
of co-infection,
secondary infection should be taken into account. Conclusions. In conclusion, it should
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) , trials had to collect data on at least one of our primary (disability score or independence) or
secondary